Wirk, B., & Lim, J. (2025). Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. Journal of Hematology. https://doi.org/10.14740/jh2046